Astec LifeSciences Limited — Board Meeting, 28-03-2025: Outcome of Board Meeting

The Board of Directors has approved the appointment of Mr. Burjis Godrej as the Managing Director for a term of five years, effective from April 1, 2025. His appointment is pending shareholder approval. Mr. Godrej, currently a Non-Executive Director, has extensive experience in product development and business strategies, having completed his MBA from Harvard. Additionally, the Board has sanctioned seeking shareholder consent via Postal Ballot for this appointment. This strategic move aims to enhance leadership continuity within the company.